LONDON, UK: In 2018, GlaxoSmithKline (GSK), one of the world’s largest pharmaceutical companies, outlined its intention to separate its consumer healthcare portfolio into an independent entity. This is set to take place in mid-2022, and GSK has now revealed that the new company will be called Haleon.
The separation of GSK’s healthcare business, which is subject to approval from shareholders, will take place via a demerger of at least 80% of GSK’s stake in the business to shareholders later this year. According to a press release issued by GSK, Haleon’s name is derived from the words “hale”, an old English word meaning “in good health”, and “Leon”, a name associated with strength. Included in Haleon’s portfolio will be the paracetamol brand Panadol, the non-steroidal anti-inflammatory Voltaren and the toothpaste brand Sensodyne.
In January, GSK revealed that it had recently rejected three takeover offers for its consumer healthcare business from multinational conglomerate Unilever, including a bid of £50 billion (approximately US$67 billion). GSK said that Unilever had undervalued the business and forecast annual organic sales growth of 4 to 6%.
“Introducing Haleon to the world marks another step in our journey to become a new, standalone company,” said Haleon CEO designate Brian McNamara. “Our name is grounded in our purpose to deliver better everyday health with humanity and to be a world leader in consumer healthcare. We are on track to launch Haleon in mid-2022 and our business momentum is strong.”
Emma Walmsley, GSK CEO, added that “Haleon has enormous potential to improve health and well-being across the world with strong prospects for growth, and through listing will unlock significant value for GSK shareholders”.
Tags:
LONDON, UK: The UK’s Insolvency Service in London has announced its disqualification of the director of a London-based dental clinic. India-born Dr ...
LONDON, UK: The Privy Council of the General Dental Council (GDC) has approved the appointment of William (Bill) Moyes as chair for another term. He will ...
LONDON, UK: The acquisition of the Oasis Healthcare Group has been completed, the Bupa health care group has said. The news comes after the European ...
NOTTINGHAM, UK: Just introduced to dental markets in the UK last year, enigmalife+ denture teeth from Schottlander recently scooped a Trade Award from the ...
LONDON, UK: The chief executives of nine of the UK’s healthcare statutory regulators have released a joint statement stressing the benefits and importance...
Aligner Dental Academy is a next-level education and support for dentists striving to deliver gold standard aligner therapy and accredit their work.
LONDON, UK: Since 2013, patients in the UK have been able to find dental and other health care providers and book appointments via the Zesty website. A new ...
LONDON, UK: A report from Amnesty International, released last month, has revealed that more than 3,000 healthcare workers worldwide have died as a result ...
GILLINGHAM, UK: Five graduates from King’s College London Dental Institute have been awarded bursaries by Henry Schein UK this year. The dental ...
CHESHAM – The British Dental Trade Association (BDTA), which represents manufacturers and suppliers of dental products, services and technologies ...
Live webinar
Fri. 19 July 2024
1:00 am UTC (London)
Live webinar
Tue. 6 August 2024
11:00 pm UTC (London)
Live webinar
Wed. 14 August 2024
12:00 am UTC (London)
Live webinar
Wed. 14 August 2024
5:30 pm UTC (London)
Live webinar
Wed. 21 August 2024
2:00 pm UTC (London)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Thu. 29 August 2024
1:00 am UTC (London)
Live webinar
Mon. 2 September 2024
10:00 am UTC (London)
To post a reply please login or register